Embelia concinna extract comprising flavonoids in cosmetic and pharmaceutical compositions
AssigneeBayer Consumer Care AG
InventorsVirginie Petit, Eric Theron
Life of this patent
Estimating the term…
Abstract
The present invention deals with an Embelia extract—preferably an extract from Embelia concinna titrated in flavonoids—, its process for preparation and its use in a cosmetical or pharmaceutical composition for the treatment of skin sensitivity, for the treatment of allergic reactions of the skin, for soothing and for the treatment of itching skin and for the regulation of inflammatory drifts in the skin.
Claims15
(canceled)
An Embelia leaf extract of claim 3 characterized in that it is a liquid extract with 1% to 8% dry matter content in a water-glycerine blend.
An Embelia leaf extract characterized in that it comprises flavonoids in an amount of more than 3% by weight with respect to the total dry plant extract.
(canceled)
9-11. (canceled)
14-15. (canceled)
A process for the preparation of an Embelia leaf extract characterized in that it is obtained by the following process steps:
- a. Extraction of the leaves with a polar solvent mixture of water and alcohol,
- b. removal of the alcohol,
- c. filtration
- d. partial or entire removal of the solvent from the aqueous filtrate.
Dependencies are inferred from the claim text.